X-Linked Retinitis Pigmentosa Clinical Trial
Official title:
Phase 3 Study to Evaluate the Safety and Efficacy of AAV5-hRKp.RPGR for the Treatment of Japanese X-linked Retinitis Pigmentosa Associated With Pathogenic Variants in Retinitis Pigmentosa GTPase Regulator (RPGR)
The purpose of the study is to assess the safety and tolerability of bilateral subretinal delivery of adeno-associated virus vector with a serotype 5 capsid human rhodopsin kinase promoter. retinitis pigmentosa guanosine triphosphatase regulator (AAV5-hRKp.RPGR).
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04926129 -
Natural History of the Progression of X-Linked Retinitis Pigmentosa
|
||
Enrolling by invitation |
NCT06275620 -
A Study Comparing Two Doses of AGTC-501 in Male Participants With X-linked Retinitis Pigmentosa Caused by RPGR Mutations (DAWN)
|
Phase 2 | |
Completed |
NCT03116113 -
A Clinical Trial of Retinal Gene Therapy for X-linked Retinitis Pigmentosa Using BIIB112
|
Phase 1/Phase 2 | |
Recruiting |
NCT04850118 -
A Clinical Trial Evaluating the Safety and Efficacy of a Single Subretinal Injection of AGTC-501 in Participants With XLRP
|
Phase 2/Phase 3 | |
Active, not recruiting |
NCT04517149 -
4D-125 in Patients With X-Linked Retinitis Pigmentosa (XLRP)
|
Phase 1/Phase 2 | |
Enrolling by invitation |
NCT03584165 -
Long-term Safety and Efficacy Follow-up of BIIB111 for the Treatment of Choroideremia and BIIB112 for the Treatment of X-Linked Retinitis Pigmentosa
|
Phase 3 | |
Active, not recruiting |
NCT04312672 -
Long-term Follow-up Gene Therapy Study for RPGR- XLRP
|
||
Completed |
NCT04868916 -
An Observational Study of Japanese Participants With X-linked Retinitis Pigmentosa
|
||
Completed |
NCT03252847 -
Gene Therapy for X-linked Retinitis Pigmentosa (XLRP) - Retinitis Pigmentosa GTPase Regulator (RPGR)
|
Phase 1/Phase 2 | |
Recruiting |
NCT05874310 -
Gene Therapy for Subjects With RPGR Mutation-associated X-linked Retinitis Pigmentosa
|
Early Phase 1 | |
Active, not recruiting |
NCT04671433 -
Gene Therapy Trial for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene
|
Phase 3 | |
Active, not recruiting |
NCT04794101 -
Follow-up Gene Therapy Trial for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene
|
Phase 3 | |
Completed |
NCT03314207 -
Clinical Evaluation of Patients With X-linked Retinitis Pigmentosa (XLRP)
|
||
Active, not recruiting |
NCT03316560 -
Safety and Efficacy of rAAV2tYF-GRK1-RPGR in Subjects With X-linked Retinitis Pigmentosa Caused by RPGR Mutations
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT06333249 -
A Study Comparing Two Doses of AGTC-501 in Male Subjects With X-linked Retinitis Pigmentosa Caused by RPGR Mutations (SKYLINE)
|
Phase 2 |